Holen Sie sich die Stockscreener-App
3.23
2.71%
-0.09
Handel nachbörslich:
3.20
-0.03
-0.93%
Schlusskurs vom Vortag:
$3.32
Offen:
$3.31
24-Stunden-Volumen:
1.61M
Relative Volume:
0.35
Marktkapitalisierung:
$348.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-258.08M
KGV:
-1.1745
EPS:
-2.75
Netto-Cashflow:
$-202.32M
1W Leistung:
-3.58%
1M Leistung:
+5.21%
6M Leistung:
-62.70%
1J Leistung:
-81.90%
1-Tages-Spanne:
$3.16
$3.3503
1-Wochen-Bereich:
$3.16
$3.3988
52-Wochen-Spanne:
$2.19
$22.01
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Firmenname
Rocket Pharmaceuticals Inc
Sektor
Branche
Telefon
646-440-9100
Adresse
350 FIFTH AVENUE, NEW YORK, NY
Vergleichen Sie RCKT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.23 | 349.61M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-07-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-30 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-05-28 | Herabstufung | Goldman | Neutral → Sell |
| 2025-05-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-28 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-28 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | Herabstufung | Needham | Buy → Hold |
| 2025-05-27 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-12 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-12-30 | Eingeleitet | Wedbush | Outperform |
| 2024-12-18 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-04-02 | Eingeleitet | Goldman | Neutral |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-11-01 | Eingeleitet | BTIG Research | Buy |
| 2022-07-08 | Eingeleitet | Raymond James | Outperform |
| 2021-10-20 | Fortgesetzt | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-08 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Eingeleitet | JP Morgan | Overweight |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2019-11-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-09-26 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-04-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-03-15 | Eingeleitet | BofA/Merrill | Buy |
| 2019-02-05 | Eingeleitet | Oppenheimer | Outperform |
| 2018-09-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-10 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten
Leading vs lagging indicators on Rocket Pharmaceuticals Inc. Equity Warrant performanceTrade Risk Report & Free Long-Term Investment Growth Plans - Newser
Order flow analysis tools used on Rocket Pharmaceuticals Inc.2025 Institutional Moves & Weekly High Potential Alerts - Newser
Custom watchlist performance reports with Rocket Pharmaceuticals Inc. Equity WarrantWeekly Risk Report & AI Powered Buy and Sell Recommendations - Newser
Can trapped investors hope for a rebound in Rocket Pharmaceuticals Inc.Trade Analysis Summary & Verified Entry Point Detection - Newser
Is a relief rally coming for Rocket Pharmaceuticals Inc. Equity Warrant holdersJuly 2025 Recap & Safe Investment Capital Preservation Plans - Newser
Will Rocket Pharmaceuticals Inc. continue its uptrendPortfolio Return Summary & Capital Protection Trade Alerts - Newser
Detecting price anomalies in Rocket Pharmaceuticals Inc. Equity Warrant with AI2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Will Rocket Pharmaceuticals Inc. Equity Warrant bounce back from current support2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser
Technical Models Detect Momentum Build in Rocket Pharmaceuticals Inc.Day Trade & High Return Stock Watch Alerts - beatles.ru
Tools to assess Rocket Pharmaceuticals Inc. Equity Warrant’s risk profileDividend Hike & Verified Trade Idea Suggestions - Newser
Should you hold or exit Rocket Pharmaceuticals Inc. Equity Warrant now2025 Buyback Activity & Expert Approved Trade Ideas - Newser
Real time alert setup for Rocket Pharmaceuticals Inc. performance2025 Sector Review & Safe Entry Zone Tips - Newser
Pattern recognition hints at Rocket Pharmaceuticals Inc. upsideMarket Sentiment Report & Long-Term Safe Investment Plans - Newser
Can momentum traders help lift Rocket Pharmaceuticals Inc. Equity WarrantEarnings Overview Summary & Real-Time Market Sentiment Reports - Newser
Applying Elliott Wave Theory to Rocket Pharmaceuticals Inc. Equity WarrantJuly 2025 Earnings & High Win Rate Trade Alerts - Newser
Using flow based indicators on Rocket Pharmaceuticals Inc.Fed Meeting & Real-Time Sentiment Analysis - Newser
Smart tools for monitoring Rocket Pharmaceuticals Inc.’s price action2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
Intraday pattern recognizer results for Rocket Pharmaceuticals Inc.Earnings Growth Report & Risk Controlled Daily Plans - Newser
Rocket Pharmaceuticals Inc. stock prediction for this weekWeekly Profit Report & Reliable Volume Spike Trade Alerts - Newser
How to build a custom watchlist for Rocket Pharmaceuticals Inc.2025 Key Lessons & Fast Exit and Entry Trade Guides - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant reversing from oversold territoryWeekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
Combining price and volume data for Rocket Pharmaceuticals Inc.July 2025 WrapUp & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-03 01:39:22 - Newser
Visualizing Rocket Pharmaceuticals Inc. stock with heatmapsInsider Selling & Expert-Curated Trade Recommendations - Newser
Rocket Pharmaceuticals Inc. stock momentum explainedMarket Sentiment Report & Entry Point Confirmation Alerts - Newser
Analyzing recovery setups for Rocket Pharmaceuticals Inc. investorsFed Meeting & Safe Capital Allocation Plans - Newser
Will Rocket Pharmaceuticals Inc. outperform the marketEarnings Risk Summary & High Accuracy Trade Signal Alerts - Newser
How to build a custom watchlist for Rocket Pharmaceuticals Inc. Equity WarrantInflation Watch & AI Forecasted Stock Moves - Newser
How sensitive is Rocket Pharmaceuticals Inc. Equity Warrant to inflationEntry Point & AI Enhanced Trading Alerts - khodrobank.com
Is Rocket Pharmaceuticals Inc. stock ready for a breakoutQuarterly Growth Report & High Yield Stock Recommendations - Newser
When is the best time to exit Rocket Pharmaceuticals Inc.July 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Key resistance and support levels for Rocket Pharmaceuticals Inc.Market Volume Summary & Target Return Focused Stock Picks - Newser
Applying chart zones and confluence areas to Rocket Pharmaceuticals Inc.July 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - Newser
Reversal indicators forming on Rocket Pharmaceuticals Inc. stockJuly 2025 Big Picture & Low Drawdown Investment Ideas - Newser
Is Rocket Pharmaceuticals Inc. stock a good pick for beginnersJuly 2025 PreEarnings & Fast Entry Momentum Alerts - khodrobank.com
Rocket Pharmaceuticals, Inc. (RCKT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Rocket Pharmaceuticals Inc. Equity Warrant forming a bottoming base2025 Biggest Moves & Fast Moving Market Watchlists - Newser
Advanced analytics toolkit walkthrough for Rocket Pharmaceuticals Inc.Weekly Earnings Recap & Low Drawdown Trading Techniques - Newser
Can machine learning forecast Rocket Pharmaceuticals Inc. recoveryWeekly Gains Summary & Long Hold Capital Preservation Plans - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant a candidate for recovery playEarnings Summary Report & Weekly Top Gainers Alerts - Newser
How cyclical is Rocket Pharmaceuticals Inc.’s revenue streamJuly 2025 Summary & Community Consensus Trade Alerts - khodrobank.com
Trend Dashboard Flags Rocket Pharmaceuticals Inc. As Potential Swing Trade getLinesFromResByArray error: size == 0 - kangso.co.kr
Rocket Pharmaceuticals Inc. Equity Warrant stock daily chart insightsJuly 2025 PreEarnings & Long Hold Capital Preservation Plans - Newser
What is Rocket Pharmaceuticals Inc. Equity Warrant’s market position2025 Fundamental Recap & Smart Investment Allocation Insights - khodrobank.com
What is the next catalyst for Rocket Pharmaceuticals Inc.2025 Buyback Activity & AI Powered Market Entry Ideas - khodrobank.com
Inflation Data: Can Rocket Pharmaceuticals Inc. Equity Warrant reach all time highs this yearWeekly Loss Report & Daily Technical Stock Forecast Reports - khodrobank.com
Rocket Pharma’s SWOT analysis: gene therapy stock faces pivotal moment - Investing.com
Can Rocket Pharmaceuticals Inc. Equity Warrant weather a recessionJuly 2025 Technicals & Low Risk Growth Stock Ideas - khodrobank.com
Will Rocket Pharmaceuticals Inc. price bounce be sustainableWeekly Gains Summary & Detailed Earnings Play Strategies - Newser
Published on: 2025-09-02 00:02:23 - khodrobank.com
Are Bears Losing Grip on Rocket Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rocket Pharmaceuticals Inc-Aktie (RCKT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Militello John | See Remarks |
Aug 18 '25 |
Sale |
3.06 |
699 |
2,142 |
56,285 |
| Militello John | See Remarks |
Aug 19 '25 |
Sale |
3.00 |
361 |
1,082 |
55,924 |
| Schwartz Jonathan David | See Remarks |
Aug 18 '25 |
Sale |
3.06 |
1,680 |
5,149 |
222,414 |
| Schwartz Jonathan David | See Remarks |
Aug 19 '25 |
Sale |
3.00 |
805 |
2,412 |
221,609 |
| Wilson Martin | General Counsel |
Aug 18 '25 |
Sale |
3.06 |
1,004 |
3,077 |
136,050 |
| Wilson Martin | General Counsel |
Aug 19 '25 |
Sale |
3.00 |
588 |
1,762 |
135,462 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):